Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sylvia Fitting

Showing results (41-50 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 19, 2014
Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overloadSylvia Fitting, Pamela E Knapp, Shiping Zou, et al.
The American Journal of Pathology|July 24, 2010
Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neuronsSylvia Fitting, Ruqiang Xu, Cecilia Bull, et al.
Retrovirology|June 30, 2024
In situ analysis of neuronal injury and neuroinflammation during HIV-1 infectionJenna B Honeycutt, Angela Wahl, Jacob K Files, et al.
Neuroimmune Pharmacology and Therapeutics|April 30, 2026
HIV-1 Tat expression drives progressive synaptic decline: evidence from longitudinal [<sup>11</sup>C]-UCB-J PET imagingTara Chand Yadav, Isabella C Orsucci, Spencer V Thompson, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Preserved Barrier Integrity and Altered Immune Profiles in Chronic Cannabis Users: Potential Roles of Δ9-TetrahydrocannabinolJohn E McKinnon, Zejun Zhou, Amanda Wagner, et al.
Journal of Neurotrauma|April 4, 2012
Lateralized response of dynorphin a peptide levels after traumatic brain injuryZubair Muhammad Hussain, Sylvia Fitting, Hiroyuki Watanabe, et al.
Molecular and Cellular Neurosciences|July 23, 2017
Endocannabinoids exert CB<sub>1</sub> receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat proteinChangqing Xu, Douglas J Hermes, Blessing Nwanguma, et al.
Neuroimmune Pharmacology and Therapeutics|January 1, 2025
Cannabis use, oral dysbiosis, and neurological disordersAmber A Hazzard, Marice McCrorey, Tabinda Salman, et al.
Journal of Neurovirology|May 15, 2016
HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulationsWilliam D Marks, Jason J Paris, Christina J Schier, et al.
Plos One|June 24, 2024
Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male miceBarkha J Yadav-Samudrala, Hailey Dodson, Shreya Ramineni, et al.
Pageof 8

Showing results (41-50 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 19, 2014
Interactive HIV-1 Tat and morphine-induced synaptodendritic injury is triggered through focal disruptions in Na⁺ influx, mitochondrial instability, and Ca²⁺ overloadSylvia Fitting, Pamela E Knapp, Shiping Zou, et al.
The American Journal of Pathology|July 24, 2010
Interactive comorbidity between opioid drug abuse and HIV-1 Tat: chronic exposure augments spine loss and sublethal dendritic pathology in striatal neuronsSylvia Fitting, Ruqiang Xu, Cecilia Bull, et al.
Retrovirology|June 30, 2024
In situ analysis of neuronal injury and neuroinflammation during HIV-1 infectionJenna B Honeycutt, Angela Wahl, Jacob K Files, et al.
Neuroimmune Pharmacology and Therapeutics|April 30, 2026
HIV-1 Tat expression drives progressive synaptic decline: evidence from longitudinal [<sup>11</sup>C]-UCB-J PET imagingTara Chand Yadav, Isabella C Orsucci, Spencer V Thompson, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2026
Preserved Barrier Integrity and Altered Immune Profiles in Chronic Cannabis Users: Potential Roles of Δ9-TetrahydrocannabinolJohn E McKinnon, Zejun Zhou, Amanda Wagner, et al.
Journal of Neurotrauma|April 4, 2012
Lateralized response of dynorphin a peptide levels after traumatic brain injuryZubair Muhammad Hussain, Sylvia Fitting, Hiroyuki Watanabe, et al.
Molecular and Cellular Neurosciences|July 23, 2017
Endocannabinoids exert CB<sub>1</sub> receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat proteinChangqing Xu, Douglas J Hermes, Blessing Nwanguma, et al.
Neuroimmune Pharmacology and Therapeutics|January 1, 2025
Cannabis use, oral dysbiosis, and neurological disordersAmber A Hazzard, Marice McCrorey, Tabinda Salman, et al.
Journal of Neurovirology|May 15, 2016
HIV-1 Tat causes cognitive deficits and selective loss of parvalbumin, somatostatin, and neuronal nitric oxide synthase expressing hippocampal CA1 interneuron subpopulationsWilliam D Marks, Jason J Paris, Christina J Schier, et al.
Plos One|June 24, 2024
Cannabinoid receptor 1 positive allosteric modulator ZCZ011 shows differential effects on behavior and the endocannabinoid system in HIV-1 Tat transgenic female and male miceBarkha J Yadav-Samudrala, Hailey Dodson, Shreya Ramineni, et al.
Pageof 8